5-10
2026
影响因子区间
—
平台估算
27%
2025
中国作者发文占比
1969 USD
收费
期刊简介:Artificial Cells, Nanomedicine and Biotechnology covers the frontiers of interdisciplinary research and application, combining artificial cells, nanotechnology, nanobiotechnology, biotechnology, molecular biology, bioencapsulation, novel carriers, stem cells and tissue engineering. Emphasis is on basic research, applied research, and clinical and industrial applications of the following topics:artificial cellsblood substitutes and oxygen therapeuticsnanotechnology, nanobiotecnology, nanomedicinetissue engineeringstem cellsbioencapsulationmicroencapsulation and nanoencapsulationmicroparticles and nanoparticlesliposomescell therapy and gene therapyenzyme therapydrug delivery systemsbiodegradable and biocompatible polymers for scaffolds and carriersbiosensorsimmobilized enzymes and their usesother biotechnological and nanobiotechnological approachesRapid progress in modern research cannot be carried out in isolation and is based on the combined use of the different novel approaches. The interdisciplinary research involving novel approaches, as discussed above, has revolutionized this field resulting in rapid developments. This journal serves to bring these different, modern and futuristic approaches together for the academic, clinical and industrial communities to allow for even greater developments of this highly interdisciplinary area.
【译文】人工细胞、纳米医学与生物技术涵盖了跨学科研究与应用的前沿,结合了人工细胞、纳米技术、纳米生物技术、生物技术、分子生物学、生物包封、新型载体、干细胞和组织工程。重点在于以下主题的基础研究、应用研究、以及临床和工业应用:人工细胞、血液代用品和氧疗、纳米技术、纳米生物技术、纳米医学、组织工程、干细胞、生物包封、微包封和纳米包封、微颗粒和纳米颗粒、脂质体、细胞治疗和基因治疗、酶治疗、药物递送系统、用于支架和载体的可生物降解和生物相容性聚合物、生物传感器、固定化酶及其应用、其他生物技术和纳米生物技术方法。现代研究的快速进展不能孤立进行,而是基于不同新颖方法的结合使用。上述涉及新颖方法的跨学科研究已经彻底改变了这一领域,导致了快速发展。这本期刊旨在将不同的、现代的、未来的方法汇集在一起,为学术、临床和工业界提供更大的发展空间。

| 指标 | 当前值 | 近三年趋势 |
|---|---|---|
| JCR分区 | Q1 | 暂无 |
| 中科院分区 | 3区 | 暂无 |
| 影响因子区间 | 5-10 | 暂无 |